Pamela T. Soliman MD(@PamSolimanMD) 's Twitter Profileg
Pamela T. Soliman MD

@PamSolimanMD

Gynecologic Oncologist @MDAndersonNews specializing in #endometrialcancer, #ovariancanver, #cervixcancer. Tweets are my own. #endcancer

ID:977903382638841857

linkhttps://faculty.mdanderson.org/profiles/pamela_soliman.html calendar_today25-03-2018 13:41:49

705 Tweets

1,8K Followers

479 Following

Follow People
Targeted Oncology(@TargetedOnc) 's Twitter Profile Photo

Shannon N. Westin, MD, MPH, evaluates tisotumab vedotin for patients with recurrent or metastatic cervical cancer. | Shannon Westin MD Anderson Cancer Center

targetedonc.com/view/second-li…

account_circle
Diane Bodurka(@DianeBodurka) 's Twitter Profile Photo

Happy 60th anniversary, MD Anderson-UTH Grad! On this day in 1963, GSBS opened its doors to 37 students seeking a master’s or Ph.D. degree in biology, biochemistry and physics. Today, GSBS has more than 3,000 alumni who’ve completed at least one of the school’s 12 degree programs. 👏

account_circle
Dr. Allison Master, @allisonmaster.bsky.social(@AllisonMaster) 's Twitter Profile Photo

Reminder--my University of Houston Assistant Professor Excellence Speaker Series talk is tomorrow (Wednesday) at 12:15 Central! There's a Teams link available for anyone who would like to join. Come learn what our research has found about key ways to encourage girls' interest in STEM!

account_circle
Team Ovary, Memorial Sloan Kettering Cancer Center(@TeamOvary_MSK) 's Twitter Profile Photo

So proud of this incredible team, and everyone who participated virtually, donated time and resources, and provided support from near and far! Thank you for your commitment to gynecologic cancer awareness and research! MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

So proud of this incredible team, and everyone who participated virtually, donated time and resources, and provided support from near and far! Thank you for your commitment to gynecologic cancer awareness and research! #Move4Her #FWC @TeamEndo_MSK @TeamOvary_MSK @MSKCancerCenter
account_circle
Amanda Nickles Fader, MD(@amandanfader) 's Twitter Profile Photo

Eight months into the worst chemo shortage in US history, we still have 15 drugs in short supply. 👀Doxil is the latest. None of these chemo agents 💉are on the FDA‘s Essential Medicines list & the current shortages disproportionately affect women. 🤦‍♀️This needs to-no MUST-change.

account_circle
Ovarcome(@ovarcome) 's Twitter Profile Photo

September is Ovarian Cancer Awareness Month. Share the 5 key facts and the 5 KEY symptoms. Let's !
B.E.A.C.H. Symptoms of Ovarian Cancer:
B= Bloating
E= Early Satiety
A= Abdominal &/or Pelvic Pain
C= Changes in Bowel/Bladder Habits
H= Heightened Fatigue

September is Ovarian Cancer Awareness Month. Share the 5 key facts and the 5 KEY symptoms. Let's #TeachTheBEACH! B.E.A.C.H. Symptoms of Ovarian Cancer: B= Bloating E= Early Satiety A= Abdominal &/or Pelvic Pain C= Changes in Bowel/Bladder Habits H= Heightened Fatigue
account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

Congratulations to our Dr. Kathleen Schmeler on being recognized by Cancer Health 25 as a champion of health equity for her work in cervical cancer screening for women in underserved communities. brnw.ch/21wBGsG Cancer Health Kathleen Schmeler MD

account_circle
Ovarcome(@ovarcome) 's Twitter Profile Photo

Both speaking at our 11th Annual Conference OVARCOMING CANCER on 9/14 and 9/15! Congratulations to you both! 🎉

account_circle
Eric Rios-Doria, MD(@RiosDoriaMD) 's Twitter Profile Photo

The SGO Board of Directors formally welcomes Dr. Fader (Amanda Nickles Fader, MD) & Dr. Lu (@karenluMD ) to their roles as President Elect I & President Elect II!

With the heavy loss of Dr. Wendy Brewster and her role as President Elect I, we have come together as a Board & determined the…

account_circle
Vivek Subbiah, MD(@VivekSubbiah) 's Twitter Profile Photo

🚨It's & we have another FDA approval 👉FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer that is mismatch repair deficient (dMMR), as determined by an FDA-approved test, or microsatellite instability-high (MSI-H).
👉Read our paper just published in…

🚨It's #monday & we have another FDA approval 👉FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer that is mismatch repair deficient (dMMR), as determined by an FDA-approved test, or microsatellite instability-high (MSI-H). 👉Read our paper just published in…
account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

We’re expanding our global oncology work in Mozambique and Brazil to include a new four-year agreement broadening existing cancer prevention and treatment efforts and a $5.1 million NIH grant to advance research. fal.cn/3AdqC

account_circle